Mount Sinai Morningside — New York, New York

Mount Sinai Morningside is a clinical research site located in New York, New York, United States 10025.

Crixeo Clinical Trials Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Mount Sinai Morningside has participated in 17 clinical trials with 14 currently active.

Therapeutic areas: COVID-19, Aortic Stenosis, Mitral Stenosis.

Sponsors: Kinevant Sciences GmbH, Edwards Lifesciences, Novo Nordisk A/S.

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai Morningside?

Mount Sinai Morningside has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai Morningside conducted?

Mount Sinai Morningside has 17 clinical trials on record, with 14 currently active. Their work covers COVID-19, Aortic Stenosis, Mitral Stenosis.

Is Mount Sinai Morningside accredited by Crixeo Clinical Trials?

Mount Sinai Morningside has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sinai Morningside?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.